Satellos Bioscience Inc. (MSLE)
NASDAQ: MSLE · Real-Time Price · USD
6.42
-0.21 (-3.17%)
At close: Oct 23, 2026, 4:00 PM EDT
6.51
+0.09 (1.40%)
After-hours: Oct 23, 2026, 4:10 PM EDT

Satellos Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
138899637726
Market Cap Growth
41.12%-6.65%160.46%440.53%-73.94%-
Enterprise Value
7654793421
Last Close Price
6.425.887.083.902.069.72

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.313.212.031.192.733.15
P/TBV Ratio
2.313.212.031.32-9.86

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-1.03-1.00-1.03-0.97-0.57-0.46
Net Debt / EBITDA Ratio
1.731.052.382.560.241.06
Net Debt / FCF Ratio
2.131.172.663.410.340.97
Quick Ratio
10.696.8413.6711.080.772.57
Current Ratio
11.227.7714.1611.130.792.59
Return on Equity (ROE)
-70.45%-66.37%-54.71%-72.15%-163.48%-301.13%
Return on Assets (ROA)
-41.89%-40.02%-31.27%-38.28%-56.08%-43.45%
Return on Capital Employed (ROCE)
-59.80%-95.20%-43.20%-38.00%-250.20%-45.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-31.43%-27.86%-21.57%-32.76%-123.13%-46.99%
FCF Yield
-20.94%-26.43%-19.09%-23.92%-61.40%-15.28%
Buyback Yield / Dilution
-46.32%-52.60%-32.84%-142.17%-48.20%-35.60%
SEC Filings: 10-K · 10-Q